Deckers Outdoor Stock Rating Lowered by Wedbush (DECK)

Wedbush cut shares of Deckers Outdoor (NASDAQ: DECK) from an outperform rating to a neutral rating in a research report sent to investors on Wednesday morning. The firm currently has $45.00 price target on the stock.

“We are downgrading shares of DECK from OUTPERFORM to NEUTRAL based on valuation and what we view as a less favorable risk/reward scenario heading into the 4Q print. DECK is trading within 1% of our target valuation and we are stepping to the sidelines given uncertainty surrounding guidance.,” Wedbush’s analyst commented.

Deckers Outdoor opened at 40.84 on Wednesday. Deckers Outdoor has a 1-year low of $28.53 and a 1-year high of $81.00. The stock’s 50-day moving average is currently $40.38. The company has a market cap of $1.440 billion and a price-to-earnings ratio of 10.05.

Several other analysts have also recently commented on the stock. Analysts at Jefferies Group raised their price target on shares of Deckers Outdoor from $50.00 to $60.00 in a research note to investors on Monday, February 4th. They now have a buy rating on the stock. Separately, analysts at Zacks reiterated a neutral rating on shares of Deckers Outdoor in a research note to investors on Wednesday, January 30th. They now have a $42.00 price target on the stock. Finally, analysts at Canaccord Genuity cut their price target on shares of Deckers Outdoor from $37.00 to $35.00 in a research note to investors on Tuesday, January 22nd. They now have a hold rating on the stock.

Five analysts have rated the stock with a buy rating, and eight have given a hold rating to the company’s stock. The company currently has an average rating of overweight and an average target price of $43.43.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Car Sales in Europe Hit Record Lows
Car Sales in Europe Hit Record Lows
Woman once on Death Row to Go Free
Woman once on Death Row to Go Free
Bidding for Back Bay Parking Spaces Reaches $560,000
Bidding for Back Bay Parking Spaces Reaches $560,000
Vermont Grappling with Nation’s Second Highest Rate of Lyme disease
Vermont Grappling with Nation’s Second Highest Rate of Lyme disease
Concerns about Origins of Genetically Modified Wheat Affect US White Wheat
Concerns about Origins of Genetically Modified Wheat Affect US White Wheat


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe